<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Wound

Thorough analysis of the wound care industry.

 

Request a Demo

 

15 of the top 15 global advanced wound care companies depend on SmartTRAK!

We provide up-to-date intel on industry trends, news, financial data and competitor developments. Our team of analysts are experts in their field - all with previous industry experience. We have our finger on the pulse to bring you the most relevant and accurate data and analysis so that you can make better, more informed strategic business decisions.

5 Analysts

6 Modules

413 Companies

1347 Products

Direct Access

to our analysts when you need it.

Daily Updates

on the latest news, earnings calls, studies, patent filings, new products and more!

Analysis and Insights

featuring Quarterly Market Recaps, Interviews, Conferences and more!

Q419/FY19 ADVANCED WOUND CARE MARKET RECAP: 3M captured the number one position in the AWC space after completing the acquisition of Acelity and its KCI subsidiaries on October 11, 2019. According to SmartTRAK’s Financial Dashboard, in FY19, combined 3M and Acelity seized 22.7% of the market and generated +6.2% YoY. Revenue for Q419 was up +6.9% YoY, driven by ongoing strong performance in single-use negative pressure wound therapy and solid growth in Advanced Wound Dressings.
Susan DSC_9296c 750x750
Susan Paquette
SmartTRAK Vice President and General Manager, Wound
China is one of the fastest growing Advanced Wound Care markets globally, growing +9.4% in FY2019. International players lead the more advanced product categories like Foam, Fiber and Antimicrobials, whereas domestic players dominate in the less advanced Island dressings market. Domestic players like WEGO, Winner Medical, Zhende and ForYou Medical are leveraging their OEM experience introducing more advanced products also in the domestic market, with their own branding.
Lennart Stadler
Lennart Stadler
SmartTRAK Senior Analyst, Wound Care
Q419/FY19 US HEMOSTATS & SEALANTS MARKET RECAP: The US Hemostats and Sealants market flourished with a +5.8% increase in Q419, and advanced +5.7% for FY19. All competitors posted gains for the quarter. Sealants continued their solid growth in Q419, up +8.4% YoY, with fibrin sealants in front. Absorbable hemostats led the US Hemostats market to an expansion of +4.4% in Q419.
DougDevens 2  200x212
Doug Devens
SmartTRAK Senior Analyst, Biosurgery
Q419/FY19 US INFECTION PREVENTION: The prevention of Hospital-Acquired Infections (HAIs) continues to drive measures and practices to reduce Central Line-Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. Numerous programs and educational tools are being developed to provide measures and strategies that assist healthcare providers in the prevention and reduction of infection in acute care and other settings.
Susan Paquette Susan Paquette, MS, MBA
Susan Paquette, MS, MBA
SmartTRAK Vice President and General Manager, Wound
Q419/FY19 US SURGICAL MATRICES MARKET RECAP: In Q419, the US Surgical Matrices Market grew +8.5% YoY, up +4.2% for FY19 according to BioMedGPS’ SmartTRAK Financial Dashboard. Allergan broke out of its Alloderm supply constraints, gaining +10.2% Yo. Becton Dickinson (BD) also did quite well, growing +5.9% YoY.
DougDevens 2  200x212
Doug Devens
SmartTRAK Senior Analyst, Biosurgery
US COMPRESSION THERAPY MARKET: The increased prevalence of lymphedema will continue to generate greater awareness, diagnosis and demand for compression therapy. Lymphedema prevalence in the US is estimated to be 5MM, and when the top 5 EU countries are included, the number increases to 10MM.
Terry Hayslett
Terry Hayslett
Senior Analyst, Advanced Wound Care
Europe is the largest market, representing 45.2% of WW Advanced Dressings in FY2019 according to SmartTRAK’s Financial Dashboard, resulting from companies’ continuous activity in Europe to introduce new products as an answer to the ageing population issue, to the reimbursement challenges and to the increasing number of chronic wounds. New technologies are expected to bring more solutions in the near future, though a lot of work still needs to be done to increase awareness of these technologies.
Anikó Szekér
Anikó Szekér
SmartTRAK Senior Analyst, Wound Care
 

Wound Modules

MODULE DETAILS

Advanced Wound Care - US/WW

Medical devices and biologics for the treatment of chronic wounds (Venous, Pressure, Diabetic Foot and Arterial Ulcers), burns, surgical and trauma wounds.

  • Advanced Dressings
  • Wound Biologics 
  • Diagnostic Aids 
  • External Devices 

 

Conventional Wound Care - US/WW

Compression devices for the treatment and prevention of venous and arterial insufficiencies and wounds, as well as lymphedema.

  • Compression Therapy

Infection Prevention - US

Vascular Access adjunct products to aid in the reduction of catheter-related bloodstream infections.

  • Vascular Access Adjunct Products

Biosurgery - US

Biologics and synthetically derived products used in surgical applications to stop the flow of blood, lymphatic fluid or air during and post-surgery.

  • Hemostats & Sealants

Surgical Matrices - US

Synthetic, biologic, and bioresorbable matrices for breast reconstruction and hernia repair.

  • Breast Reconstruction 
  • Hernia Repair 
Regional
  • EU Advanced Dressings – Separate country Segments for: France, Germany, Italy, Spain and UK
  • ROW Advanced Dressings – Country Segment for China
  • EU Negative Pressure Wound Therapy (NPWT) – Separate country Segments for: France, Germany, Nordics, and UK

 

New call-to-action

 

Analysis

SmartTRAK Analysis features curated content by our team of industry experts bringing the most relevant information and insight directly to you. Learn about the latest news, emerging technologies or start-ups to watch, conference happenings and more via articles, videos, and interviews we do. Our analysts keep you up-to-date on the latest market trends and competitive developments in our daily updates, quarterly market recaps and market overviews.

 

Wound Markets

SmartTRAK gives you the most comprehensive coverage of major segments of the Wound Care industry. SmartTRAK Market Overviews provide a complete and up-to-date snapshot of what’s driving a market, what’s limiting growth and what new technologies are coming on the scene. From procedure volumes and 5-year forecasts to competitive shares, SmartTRAK Market Overviews contain the latest data and insights on Incidence & prevalence, new treatments and technologies, regulatory and reimbursement.

Download Modules & Segments PDF

 

Company Profiles

SmartTRAK profiles all of the public, private and not-for-profit players participating in a market segment. Succinct and up-to-date, each company profile is consistently formatted so you can make an apples-to-apples comparison of revenues, financings, product portfolios, acquisitions and strategic partnerships. Perfect for competitive analysis or M&A research.

 

Product Profiles

Product Profiles are robust and give an in-depth look into the most current information on a particular product. Each product profile includes a description of the technology, summary of clinical studies, regulatory approvals, sales and more —all with links to the original source.  Product profiles provide all of the information you need to size up a competitive product or learn about a new one.

 

Product Explorer Tool

Product Explorer Tool enables you to quickly drill down on the wound market by segment, indication, regulatory status and more giving you an up-to-date view of the global competitive landscape in seconds.

 

Financial Dashboard Tool

Quickly size a market, gauge market share, compare year over year growth and spot trends. Users can sort data by market, segment, sub-segment, on quarterly or annual basis and can easily get the financial data they need.

 

Gap Analysis Tool

Quickly visualize your or your competitor’s product portfolio in seconds! Users can quickly see gaps in their own offering and identify potential candidates for acquisition targets t0 potentially strengthen their own portfolio.